Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The extracellular tumor microenvironment (TME) pH buffering system is a critical physiological target characterized by the regulation of proton concentrations in the space surrounding malignant cells (Vaupel & Multhoff, 2021). In most solid tumors, metabolic reprogramming—specifically the Warburg effect—leads to the overproduction of lactic acid and protons, resulting in a chronically acidic extracellular environment with a pH typically ranging from 6.5 to 6.9 (Gatenby & Gillies, 2004). This acidosis serves as a driver for cancer progression by promoting extracellular matrix degradation and facilitating local invasion and distant metastasis (Robey et al., 2009). Furthermore, the acidic TME acts as a potent immunosuppressive barrier, impairing the function of cytotoxic T lymphocytes while favoring pro-tumorigenic immune cells (Pilon-Thomas et al., 2016). Therapeutic interventions targeting this system involve the use of systemic buffering agents, such as sodium bicarbonate, or targeted delivery systems like pH-low insertion peptides (pHLIP) to neutralize acidity (Reshetnyak et al., 2006). By restoring a more neutral pH, these treatments aim to sensitize tumors to conventional therapies and enhance the efficacy of immune checkpoint inhibitors (Pilon-Thomas et al., 2016).
Direct neutralization of extracellular protons or systemic administration of buffering agents to increase the pH of the tumor microenvironment, thereby reversing acidosis-induced immunosuppression and chemoresistance (Pilon-Thomas et al., 2016; Robey et al., 2009).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular tumor microenvironment pH buffering system (TME pH system).